You just read:

Calliditas Therapeutics and Everest Medicines Enter into an Agreement to Develop and Commercialize Nefecon for IgA Nephropathy in Greater China and Singapore

News provided by

Calliditas Therapeutics

10 Jun, 2019, 07:19 BST